Biotechs emerge as important players in 2012
18.01.12 Brussels – Predicting the future is often not more than a guessing game. But two signs recently appeared on the horizon which indicate that the biotechnology industry will play a dominant role in the dynamics of EU economics in... moreConsortium of seven European countries tackles multiple myeloma
03.01.12 Innsbruck/Brussels - Twelve institutions in seven countries are working together to learn more about how one of the deadliest cancers interacts with its environment. The consortium OPTATIO (OPtimizing TArgets and Therapeutics In... moreEMA to refine biosimilar rules
19.12.11 London – The EMA has proposed revising its guidelines for biosimilar products. In mid-November the Agency said that the current “conceptual” guidelines – which date back to 2005, when no biosimilar products were marketed in the... moreNew members on Board
16.12.11 Swedish Pharmalink AB (Stockholm) has elected Anders Wiklund to serve as its new Chairman of the Board, which will also be strengthened by former Diamyd CEO and President Elisabeth Lindner. Pharmalink’s founder and former... moreIs that a glimmer of sunshine I see on the horizon?
16.12.11 Brussels – At the end of November, the European Commission coyly lifted its skirts for an ankle-flash of the innovation and research programme that will replace FP7 – the long awaited Horizon 2020. FP7 has evolved well for many... more
More news from 'Insight Europe': Politics & Law Biofunding BioPeople Miscellaneous